Nectar Lifesciences

Country/Region: India     State/Province: New Delhi

Company Introduction
With years of affluent industry expertise and experience, Nectar Lifesciences LLC takes pride in providing an extensive range of Cephalosporines along with Cephalosporines. Our Cephalosporines is quality assured and comply with international industry standards which is very important to us owing to the international export market share including Australia,Canada,Germany,South Korea,Poland. Buyers can expect superior grade pieces, reliability and admirable specifications in price, having no match. It helped us expand our consumer base and in no time we reached Approx 2 Million US Dollar worth of annual revenue.The high-tech storage facility and an ultramodern inventory management system launched with initial business capital of US$2.5 Million - US$5 Million and sufficient production capacity caters to US$10 Million - US$50 Million of export value, keeping the consumer reliability in check. Nectar Lifesciences is a located in NEW DELHI, , India operating under Third Party, but boast a vast distribution network, it has always been easy for us to deliver bulk and retail orders. Being a reputable Manufacturer and Supplier of [keywords] since 2014, we have been successfully delivering to customers holding 6 Years of export history.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2014, 2014

Legal Status: Third Party

Ownership: LLC

Employees: 101 - 200 People

Factory Size: 1, 000-3, 000 square meters

R&D Team Size: 51 - 100 People

Certifications: ISO9001

Contact Information

Contact Person: Navlika

Designation: Administrative

Department: sales manager

Telephone: 91911723000000

Business Information

Main Markets: South Korea (29%) Australia (27%) Canada (19%) Germany (11%) Poland (11%)

Export Focus: Australia, Canada, Germany, South Korea, Poland

Contract Services: Buyer Label Offered

Trade & Financial Information

Annual Revenue: Approx 2 Million US Dollar

Registered Capital: US$2.5 Million - US$5 Million

Export Percentage: 31% - 40%

Payment Terms: Bank wire (T/T)

Product Showcase
Cephalosporines
Cephalosporines

CL-Link > Health & Medicines in India Health & Medicines in New Delhi Medicines in India Medicines in New Delhi Cephalosporines in India Cephalosporines in New Delhi